Literature DB >> 19497875

Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands.

David A Zidar1, Jonathan D Violin, Erin J Whalen, Robert J Lefkowitz.   

Abstract

CCL19 and CCL21 are endogenous agonists for the seven-transmembrane receptor CCR7. They are equally active in promoting G protein stimulation and chemotaxis. Yet, we find that they result in striking differences in activation of the G protein-coupled receptor kinase (GRK)/ss-arrestin system. CCL19 leads to robust CCR7 phosphorylation and beta-arrestin2 recruitment catalyzed by both GRK3 and GRK6 whereas CCL21 activates GRK6 alone. This differential GRK activation leads to distinct functional consequences. Although each ligand leads to beta-arrestin2 recruitment, only CCL19 leads to redistribution of beta-arrestin2-GFP into endocytic vesicles and classical receptor desensitization. In contrast, these agonists are both capable of signaling through GRK6 and beta-arrestin2 to ERK kinases. Thus, this mechanism for "ligand bias" whereby endogenous agonists activate different GRK isoforms leads to functionally distinct pools of beta-arrestin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19497875      PMCID: PMC2689814          DOI: 10.1073/pnas.0904361106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC.

Authors:  G Bardi; M Lipp; M Baggiolini; P Loetscher
Journal:  Eur J Immunol       Date:  2001-11       Impact factor: 5.532

2.  Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference.

Authors:  Seungkirl Ahn; Christopher D Nelson; Tiffany Runyan Garrison; William E Miller; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-11       Impact factor: 11.205

3.  CCL19 induces rapid dendritic extension of murine dendritic cells.

Authors:  Yoshiki Yanagawa; Kazunori Onoé
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

4.  Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors.

Authors:  R H Oakley; S A Laporte; J A Holt; M G Caron; L S Barak
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

5.  Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7.

Authors:  Trudy A Kohout; Shelby L Nicholas; Stephen J Perry; Greg Reinhart; Sachiko Junger; R Scott Struthers
Journal:  J Biol Chem       Date:  2004-03-30       Impact factor: 5.157

6.  Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2.

Authors:  Huijun Wei; Seungkirl Ahn; Sudha K Shenoy; Sadashiva S Karnik; László Hunyady; Louis M Luttrell; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-29       Impact factor: 11.205

7.  Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2.

Authors:  Seungkirl Ahn; Huijun Wei; Tiffany Runyan Garrison; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2004-01-07       Impact factor: 5.157

8.  Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins.

Authors:  Stephen J Perry; George S Baillie; Trudy A Kohout; Ian McPhee; Maria M Magiera; Kok Long Ang; William E Miller; Alison J McLean; Marco Conti; Miles D Houslay; Robert J Lefkowitz
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

9.  Determinants of high-affinity binding and receptor activation in the N-terminus of CCL-19 (MIP-3 beta).

Authors:  T R Ott; F M Lio; D Olshefski; X-J Liu; R S Struthers; N Ling
Journal:  Biochemistry       Date:  2004-03-30       Impact factor: 3.162

10.  Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells.

Authors:  V N Ngo; H L Tang; J G Cyster
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

View more
  120 in total

Review 1.  Mechanisms regulating chemokine receptor activity.

Authors:  Laura D Bennett; James M Fox; Nathalie Signoret
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  Deciphering biased-agonism complexity reveals a new active AT1 receptor entity.

Authors:  Aude Saulière; Morgane Bellot; Hervé Paris; Colette Denis; Frédéric Finana; Jonas T Hansen; Marie-Françoise Altié; Marie-Hélène Seguelas; Atul Pathak; Jakob L Hansen; Jean-Michel Sénard; Céline Galés
Journal:  Nat Chem Biol       Date:  2012-05-27       Impact factor: 15.040

Review 3.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

4.  Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells.

Authors:  Christian Doll; Florian Pöll; Kenneth Peuker; Anastasia Loktev; Laura Glück; Stefan Schulz
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

5.  Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling.

Authors:  Ishan Roy; Donna M McAllister; Egal Gorse; Kate Dixon; Clinton T Piper; Noah P Zimmerman; Anthony E Getschman; Susan Tsai; Dannielle D Engle; Douglas B Evans; Brian F Volkman; Balaraman Kalyanaraman; Michael B Dwinell
Journal:  Cancer Res       Date:  2015-09-01       Impact factor: 12.701

Review 6.  G Protein-coupled Receptor Biased Agonism.

Authors:  Sima Y Hodavance; Clarice Gareri; Rachel D Torok; Howard A Rockman
Journal:  J Cardiovasc Pharmacol       Date:  2016-03       Impact factor: 3.105

7.  CCR7 deficiency leads to leukocyte activation and increased clearance in response to pulmonary Pseudomonas aeruginosa infection.

Authors:  Bryan L Eppert; Gregory T Motz; Brian W Wortham; Jennifer L Flury; Michael T Borchers
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

8.  Inhibition of follicle-stimulating hormone-induced preovulatory follicles in rats treated with a nonsteroidal negative allosteric modulator of follicle-stimulating hormone receptor.

Authors:  James A Dias; Brice Campo; Barbara A Weaver; Julie Watts; Kerri Kluetzman; Richard M Thomas; Béatrice Bonnet; Vincent Mutel; Sonia M Poli
Journal:  Biol Reprod       Date:  2014-01-30       Impact factor: 4.285

9.  Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.

Authors:  Nikhil M Urs; Simone Bido; Sean M Peterson; Tanya L Daigle; Caroline E Bass; Raul R Gainetdinov; Erwan Bezard; Marc G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

10.  Role of helix 8 of the thyrotropin-releasing hormone receptor in phosphorylation by G protein-coupled receptor kinase.

Authors:  Austin U Gehret; Brian W Jones; Phuong N Tran; Laurie B Cook; Emileigh K Greuber; Patricia M Hinkle
Journal:  Mol Pharmacol       Date:  2009-11-11       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.